Your browser doesn't support javascript.
loading
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Gulati, Shuchi; Hsu, Chih-Yuan; Shah, Surbhi; Shah, Pankil K; Zon, Rebecca; Alsamarai, Susan; Awosika, Joy; El-Bakouny, Ziad; Bashir, Babar; Beeghly, Alicia; Berg, Stephanie; de-la-Rosa-Martinez, Daniel; Doroshow, Deborah B; Egan, Pamela C; Fein, Joshua; Flora, Daniel B; Friese, Christopher R; Fromowitz, Ariel; Griffiths, Elizabeth A; Hwang, Clara; Jani, Chinmay; Joshi, Monika; Khan, Hina; Klein, Elizabeth J; Heater, Natalie Knox; Koshkin, Vadim S; Kwon, Daniel H; Labaki, Chris; Latif, Tahir; McKay, Rana R; Nagaraj, Gayathri; Nakasone, Elizabeth S; Nonato, Taylor; Polimera, Hyma V; Puc, Matthew; Razavi, Pedram; Ruiz-Garcia, Erika; Saliby, Renee Maria; Shastri, Aditi; Singh, Sunny R K; Tagalakis, Vicky; Vilar-Compte, Diana; Weissmann, Lisa B; Wilkins, Cy R; Wise-Draper, Trisha M; Wotman, Michael T; Yoon, James J; Mishra, Sanjay; Grivas, Petros; Shyr, Yu.
Afiliação
  • Gulati S; University of California Davis Comprehensive Cancer Center, Sacramento.
  • Hsu CY; University of Cincinnati Cancer Center, Cincinnati, Ohio.
  • Shah S; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Shah PK; Division of Hematology/Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix.
  • Zon R; Mays Cancer Center at University of Texas Health San Antonio MD Anderson.
  • Alsamarai S; Dana-Farber Cancer Institute and Massachusetts General Brigham, Boston.
  • Awosika J; Hartford HealthCare Cancer Institute, Hartford, Connecticut.
  • El-Bakouny Z; University of Cincinnati Cancer Center, Cincinnati, Ohio.
  • Bashir B; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Beeghly A; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Berg S; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee.
  • de-la-Rosa-Martinez D; Loyola University Medical Center, Chicago, Illinois.
  • Doroshow DB; Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Egan PC; Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, New York, New York.
  • Fein J; Brown University and Lifespan Cancer Institute, Providence, Rhode Island.
  • Flora DB; Hartford HealthCare Cancer Institute, Hartford, Connecticut.
  • Friese CR; St Elizabeth Healthcare, Edgewood, Kentucky.
  • Fromowitz A; University of Michigan Rogel Cancer Center, Ann Arbor.
  • Griffiths EA; Montefiore Medical Center, Albert Einstein College of Medicine, New York, New York.
  • Hwang C; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Jani C; Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan.
  • Joshi M; Mount Auburn Hospital, Boston, Massachusetts.
  • Khan H; Penn State Cancer Institute, Hershey, Pennsylvania.
  • Klein EJ; Brown University and Lifespan Cancer Institute, Providence, Rhode Island.
  • Heater NK; Brown University and Lifespan Cancer Institute, Providence, Rhode Island.
  • Koshkin VS; Loyola University Medical Center, Chicago, Illinois.
  • Kwon DH; UCSF Helen Diller Family Comprehensive Cancer Center at the University of California San Francisco.
  • Labaki C; UCSF Helen Diller Family Comprehensive Cancer Center at the University of California San Francisco.
  • Latif T; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • McKay RR; University of Cincinnati Cancer Center, Cincinnati, Ohio.
  • Nagaraj G; Moores Cancer Center, University of California San Diego.
  • Nakasone ES; Loma Linda University Cancer Center, Loma Linda, California.
  • Nonato T; Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, University of Washington, Seattle.
  • Polimera HV; Moores Cancer Center, University of California San Diego.
  • Puc M; Penn State Cancer Institute, Hershey, Pennsylvania.
  • Razavi P; Virtua Health, Marlton, New Jersey.
  • Ruiz-Garcia E; Moores Cancer Center, University of California San Diego.
  • Saliby RM; Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Shastri A; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Singh SRK; Montefiore Medical Center, Albert Einstein College of Medicine, New York, New York.
  • Tagalakis V; University of Arkansas for Medical Sciences, Little Rock.
  • Vilar-Compte D; Division of Internal Medicine and Centre for Clinical Epidemiology of the Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  • Weissmann LB; Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Wilkins CR; Mount Auburn Hospital, Boston, Massachusetts.
  • Wise-Draper TM; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Wotman MT; New York Presbyterian Hospital-Weill Cornell Medicine, New York, New York.
  • Yoon JJ; University of Cincinnati Cancer Center, Cincinnati, Ohio.
  • Mishra S; Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, New York, New York.
  • Grivas P; University of Michigan Rogel Cancer Center, Ann Arbor.
  • Shyr Y; Lifespan Cancer Institute, Providence, Rhode Island.
JAMA Oncol ; 9(10): 1390-1400, 2023 Oct 01.
Article em En | MEDLINE | ID: mdl-37589970
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / COVID-19 / Neoplasias Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / COVID-19 / Neoplasias Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article